Researchers from the PUC-Rio in Rio de Janeiro, Brazil, have found unexpectedly high uranium concentrations in groundwater samples from the mountainous region near Rio de Janeiro City.
Photo Credit: dabldy/stock.adobe.com
Researchers from the Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio) in Rio de Janeiro, Brazil, have found unexpectedly high uranium concentrations in groundwater samples from the mountainous region near Rio de Janeiro City (1). The samples contained up to 930 µg/L of uranium, approximately 30 times higher than the World Health Organization (WHO) guidance level. The figures were a cause for concern because the area contains a large amount of tourism and water-related industries, such as mineral water and breweries.
Despite its radioactive nature, the main concern from elevated uranium elements derives from its chemical toxicity, rather than its long-term radiological toxicity (2). The main threat from elevated levels of uranium being impaired kidney function (2).
Samples originating from the Rio De Janeiro state mountainous region were analyzed at PUC-Rio’s Water Characterization Laboratory (LABAGUAS), including physical-chemical assays and the determination of major cations and anions by ion chromatography, and trace elements by inductively coupled plasma–mass spectrometry (ICP-MS).
Researchers found elevated uranium concentrations in groundwater in seven of the 16 counties belonging to the Rio De Janeiro state. The wells with elevated uranium concentrations also presented high radon content, and 210Pb concentrations above the WHO guidance level of 0.1 Bq/L These findings are particularly worrying as the drilling of deep artesian wells is a growing trend in the region; researchers recommend that any new wells deeper than 80 m have mandatory testing for uranium and 222Rn as well as further studies on existing wells.
References
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.